Company
Merck
Official Name: Merck & Co., Inc.
Headquarters: Kenilworth, NJ, United States
Founded: 1891
Employees: 67,000
CEO: Mr. Robert M. Davis J.D.
Market Cap
$318.75 Billion
USD as of July 1, 2024
Company Description
Merck & Company, Inc., known as Merck Sharp & Dohme, or MSD, outside the United States and Canada, is one of the largest pharmaceutical companies in the world. Founded in 1891 in the US, and independent since World War I from its parent company, now one of the largest companies in Germany, Merck provides prescription medicines, vaccines, biologic therapies, and animal health products.
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—General
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Johnson & Johnson | $350.63 B |
| AbbVie | $295.34 B |
| AstraZeneca | $236.45 B |
| Novartis | $219.78 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| AbbVie | $295.34 B |
Detailed Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
Merck & Co., Inc. has the following listings and related stock indices.
Stock: NYSE: MRK wb_incandescent
Stock: FSX: 6MK wb_incandescent
Stock: Euronext: MRK wb_incandescent
Product & Services
Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health (list...)
Key People
Founder(s): Theodore Weicker George Merck
Kenneth C. Frazier (Executive Chairman) Robert M. Davis (President and CEO)
Financials
Revenue: US$47.994 billion (2020)
Operating income: US$8.791 billion (2020)
Net income: US$7.067 billion (2020)
Total assets: US$89.800 billion (2020)
Total equity: US$29.270 billion (2020)